Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.08.24
/
50%
€23.80
Target price
07.08.25
€18.31
Performance (%)
0.00%
Price
12.09.24
€23.80
Summary
This prediction is currently active. JPMorgan_Chase___Co_'s SELL prediction for Myriad Genetics is currently unchanged. This prediction currently runs until 07.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | 5.310% | 5.310% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $20.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat